Sign in Subscribe
Biotechnology

Concord Biotech Sees 2.10% Rise Amid Incorporation of Wholly Owned Subsidiary Company

Strategic Insights

— 1 min read

Concord Biotech, a leading biopharmaceutical company, has seen a significant rise in stock prices after incorporating a wholly owned subsidiary company, Concord Lifegen. With a current market capitalization of Rs. 20,297.64 crore, the company's stock price has touched a high of Rs. 1945.00 and a low of Rs. 1869.05, resulting in a gain of 39.80 points or 2.10% from its previous closing price of Rs. 1897.30. The company has a face value of Rs. 1 and a 52-week high of Rs. 2658.00, touching a 52-week low of Rs. 1370.05. The incorporation of Concord Lifegen aims to manage the marketing, sales, and distribution of pharmaceutical products, along with executing targeted sales strategies, ensuring regulatory compliance, and maintaining transparent reporting to the holding company.

Key Takeaways:

  • Concord Biotech has seen a 2.10% rise in stock prices, gaining 39.80 points to Rs. 1937.10.
  • The company has incorporated wholly owned subsidiary company Concord Lifegen to manage marketing, sales, and distribution of pharmaceutical products.
  • The primary objectives of Concord Lifegen include executing targeted sales strategies, ensuring regulatory compliance, handling logistics, and maintaining transparent reporting.
  • Concord Biotech has a current market capitalization of Rs. 20,297.64 crore and a face value of Rs. 1.
  • The company has a 52-week high of Rs. 2658.00 and a 52-week low of Rs. 1370.05.
  • Concord Biotech is a leading global developer and manufacturer of select fermentation-based APIs across immunosuppressants and oncology products.
  • The company's promoters hold 44.08% of its shares, while institutions and non-institutions hold 17.95% and 37.96% respectively.

Statistics:

  • Current market capitalization: Rs. 20,297.64 crore
  • Face value: Rs. 1
  • 52-week high: Rs. 2658.00 (20-Sep-2024)
  • 52-week low: Rs. 1370.05 (07-May-2025)
  • Promoters holding: 44.08%
  • Institutions holding: 17.95%
  • Non-Institutions holding: 37.96%
  • Number of shares traded: 9208
  • Trading value (high and low): Rs. 1945.00 and Rs. 1869.05

Sources:

  • Accord Fintech Pvt. Ltd. (no date)
  • Contify.com (no date)

Read more